Correction: MRI-based habitat radiomics for predicting WHO/ISUP nuclear grade in clear cell renal cell carcinoma
-
By
-
Naijing Shi
-
Cong Zhang
-
Xinyi Li
-
Mohan Hao
-
Chong Liu
-
May 18, 2026
-
Clinical Scorecard: Correction: MRI-derived habitat radiomics for forecasting WHO/ISUP nuclear grade in clear cell renal cell carcinoma
At a Glance
| Category | Detail |
|---|
| Condition | Clear Cell Renal Cell Carcinoma |
| Key Mechanisms | MRI-derived habitat radiomics |
| Target Population | Patients with clear cell renal cell carcinoma |
| Care Setting | Oncology |
Key Highlights
- Correction of test set labeling in Table 1
- Low-grade tumors: n = 79
- High-grade tumors: n = 29
- Focus on WHO/ISUP nuclear grade prediction
- Updated findings published in Frontiers in Oncology
Guideline-Based Recommendations
Diagnosis
- Utilize MRI-derived habitat radiomics for assessment
Management
- Consider nuclear grade in treatment planning
Monitoring & Follow-up
- Regular imaging to assess tumor characteristics
Risks
- Potential misclassification of tumor grade due to labeling errors
Patient & Prescribing Data
Individuals diagnosed with clear cell renal cell carcinoma
MRI-based assessments can enhance grading accuracy
Clinical Best Practices
- Ensure accurate labeling of clinical data
- Incorporate radiomics in routine assessments
- Regularly update clinical guidelines based on new findings
Related Resources & Content
